“The acquisition of AOM enhances our range of non-GMO plant-based ingredients, strengthens our access to new sources of diversified natural raw materials and opens up new end markets,” commented Serge Rogasik, CEO of Kensing. “We look forward to partnering with Alex [AOM’s CEO] and his team to meet the growing demand for natural products from our five plants across the U.S., Europe, and Latin America.”

AOM, which operates facilities in Valencia, Spain, and Buenos Aires, Argentina, is a global producer of plant-based, non-GMO products including vitamin E, mixed tocopherols, and phytosterols. Serving customers in more than 34 countries, AOM delivers clean-label alternatives that are well aligned with the preferences of brands and consumers across the nutrition, personal care, food, and beverage sectors.

“We are thrilled to join forces with an industry leader and embark on this new chapter as part of Kensing. This acquisition marks an exciting opportunity for us to leverage our combined capabilities to enhance performance and expand geographic presence. Together, we can deliver unparalleled value to customers, consumers, and stakeholders, and I look forward to the journey ahead,” said Alex Abad, CEO of AOM.

Established in 2021, Kensing, a portfolio company owned by an affiliate of One Rock, is a manufacturer of a broad range of specialty chemicals derived from vegetable oils including plant sterols, natural vitamin E, anionic surfactants and esters. Headquartered in Kankakee, IL, Kensing’s formulated ingredients serve a diverse array of customers across the home and personal care, pharmaceuticals, nutrition and agricultural markets. Kensing is recognized for its Ecovadis Gold rating.